Neurophysiologic Biomarkers in Rett Syndrome
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT05932589
- Status
- Recruiting
Conditions
- RTT
- Rett Syndrome
- Rett Syndrome, Atypical
Eligibility Criteria
- Sex
- FEMALE
- Age
- 1 Year - 18 Years
- Healthy Volunteers
- Accepted
Interventions
- EEG and Auditory and Visual Evoked Potentials (AEP and VEP) — OTHERThrough up to eight standardized sessions, participants will undergo AEP and VEP, as well as resting state EEG.
- Clinical assessment — OTHEREstablished clinical measures for RTT will be collected for RTT participants
Study Details
The goal of this observational study is to identify candidate biomarkers in individuals with Rett Syndrome (RTT). The main questions it aims to answer are: * Do these biomarkers change during clinical changes in individuals with RTT? * Are biomarkers stable over time in clinically stable individuals? * Do these biomarkers correlate with severity of RTT? Participants will be asked to undergo an electroencephalogram (EEG) with measurements of Evoked Potentials (EP) to measure electrical activity in the brain. Researchers will compare findings in individuals with RTT to those in typically developing individuals to see if there are differences between the two groups.
Key Dates
- Start date
- Oct 11, 2023
- Status verified
- Oct 2025
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 202 participants (estimated)
Arms
- Arm: RTT FemalesFemales with Rett Syndrome
- Arm: ControlsFemales with typical development
Primary Outcome Measure
Auditory Evoked Potential (AEP) latency (ms) [ Time Frame: 5 years ]
Central Contacts
- Holly Dubbs, MS. CGC215-590-1719
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | Shefali Spurling Jeste, MD (PRINCIPAL_INVESTIGATOR) Payal Kenia Gu, MD (SUB_INVESTIGATOR) |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | Timothy Benke, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Boston Children's Hospital | Brookline | Massachusetts | 02445 | April Levin, MD (PRINCIPAL_INVESTIGATOR) David Lieberman, MD, PhD (SUB_INVESTIGATOR) |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Eric Marsh, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Jeffrey Neul, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Texas Children's Hospital | Houston | Texas | 77030 | Bernhard Suter, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- Rett Syndrome RegistryRecruiting · International Rett Syndrome Foundation · Birmingham, Alabama
- A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)PHASE3 · Recruiting · Taysha Gene Therapies, Inc. · La Jolla, California
- Validating Innovative Biosensors for Rett Autonomic Symptom TrackingRecruiting · Rett Syndrome Research Trust · Chicago, Illinois
- To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett SyndromePHASE3 · Recruiting · Biomed Industries, Inc. · Phoenix, Arizona